January 24, 2023

Global Brain has invested in Visolis, Inc., a company that develops an innovative approach to make carbon-negative high-performance materials

Global Brain is delighted to announce its investment in Visolis, Inc. (Visolis), a company that makes carbon-negative high-performance materials, through its GB-VIII Growth Fund Investment Limited Partnership (GB-VIII). The funding round was led by BlueYard Capital.

Visolis provides carbon-negative materials by combining biotechnology and chemical processes, which is different from the conventional chemical manufacturing process. Bioprocesses are unique in a way that it can use renewable resources and greenhouse gases as raw materials and can carry out complex reactions that are challenging for chemical synthesis. On the other hand, there are many cases where conventional chemical catalysts have advantage over bioprocesses. By designing a reaction process that leverages the strengths of each process, Visolis can significantly reduce the cost of bringing new materials to market.

To reduce greenhouse gas emissions in the supply chain, markets are seeking materials derived from non-fossil resources. Visolis uses bioprocesses to make platform molecules, and the molecules are then used as building blocks in chemical processes to develop carbon-negative materials for diverse markets, including personal care and industrial applications.

Global Brain has decided to invest in Visolis because it sees huge potential in Visolis’ talented team and unique manufacturing approach, and in carbon-negative materials market. Global Brain will contribute to business growth of Visolis primarily by assisting its penetration into Japanese market.

About Visolis

California, US
Dr. Deepak Dugar
May 2012


GB-VIII Growth Fund Investment Limited Partnership
General Partner
Global Brain Corporation

About Global Brain

Tokyo, Japan
Yasuhiko Yurimoto
January 1998

The Global Brain mark is a registered trademark of Global Brain Corporation. Other marks and trade names are the property of their respective owners.

© 2023 Global Brain Corporation